Innovation drives CapitalBio's continuous growth in the Life Science technology field. CapitalBio also develops various cutting-edge biochips utilizing microfluidic technology, microprocessor technology and bio-electro-magnetic technology. Up to now CapitalBio has filed over 120 patent applications, the majority of which have already been issued. CapitalBio offers several Microarray Total Solutions for a range of applications:
Go here to learn more about CapitalBio's Custom Microarray Kits
Go here to learn more about CapitalBio's other Custom Kits